$SOLV News

Solventum to Participate in the 2026 Wells Fargo Healthcare Conference

Solventum (SOLV) Price Target Increased by 10.88% to 95.90

3 Reasons to Avoid SOLV and 1 Stock to Buy Instead

Are Wall Street Analysts Bullish on Solventum Stock?

Solventum (SOLV) Q2 2026 Earnings Call Transcript

SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook

Solventum (SOLV) Stock Fair Value Rises After Q2 And HIS Separation Plans

Solventum Q2 Earnings Call Highlights

UBS Maintains Buy on Solventum, Raises Price Target to $101

Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105

Solventum Corporation Q2 2026 Earnings Call Summary

Wedbush Maintains Outperform on Solventum, Raises Price Target to $101

Keybanc Maintains Overweight on Solventum, Raises Price Target to $102

Stifel Maintains Buy on Solventum, Raises Price Target to $100

Solventum plans software separation to become ‘true medtech company’

BTIG Maintains Buy on Solventum, Raises Price Target to $95

Solventum Corp (SOLV) (Q2 2026) Earnings Call Highlights: Strong Growth and Strategic ...

Solventum beats estimates, raises guidance on strong growth

Solventum (SOLV) Q2 Earnings and Revenues Top Estimates

Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates